Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC)

Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC)

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ferrier, Evan, Lemelin, Audreylie, Powles, Thomas, Pal, Sumanta Kumar, Ebrahimi, Hedyeh, Agarwal, Neeraj, Beuselinck, Benoit, Bjarnason, Georg A, Wood, Lori, Canil, Christina M, Saliby, Renee Maria, de Velasco, Guillermo, Mckay, Rana R, Tran, Ben, Suarez, Cristina, Templeton, Arnoud J, Choueiri, Toni K, Heng, Daniel Yick Chin
Format: Other
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 395
container_issue 4_SUPPL
container_start_page 395
container_title
container_volume 42
creator Ferrier, Evan
Lemelin, Audreylie
Powles, Thomas
Pal, Sumanta Kumar
Ebrahimi, Hedyeh
Agarwal, Neeraj
Beuselinck, Benoit
Bjarnason, Georg A
Wood, Lori
Canil, Christina M
Saliby, Renee Maria
de Velasco, Guillermo
Mckay, Rana R
Tran, Ben
Suarez, Cristina
Templeton, Arnoud J
Choueiri, Toni K
Heng, Daniel Yick Chin
description
format Other
fullrecord <record><control><sourceid>kuleuven_FZOIL</sourceid><recordid>TN_cdi_kuleuven_dspace_20_500_12942_751344</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20_500_12942_751344</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_20_500_12942_7513443</originalsourceid><addsrcrecordid>eNqVjMtKxEAQRbNQcHz8Qy0TYSRJJ8zoTjKKAV8MIu6amqSCrf0I3dWjX-b3mRE_QDf3cuGcu5fM8oUo58VSvBwkhyG85XlRLUU9S77WhBo-nNc9uMidMxTADTAoHxi0sgRpcZuBVVuno8ENoO1BjUor8zPT-_b5AdrHNgNlwRBjYGTVgSc7PXekp0DfKesMQmrWTZNdwKWFOPbIBIN3BviVoLVM3k6q23k7DlbIuMFA0DgbnGcVDaTt3arJjpP9AXWgk98-Sk6vr56am_l71BS3ZGUfRuxIlrms81wW5XlVykVdiKoS_4TP_gxL_mTxDfMxcVA</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>other</recordtype></control><display><type>other</type><title>Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC)</title><source>Lirias (KU Leuven Association)</source><creator>Ferrier, Evan ; Lemelin, Audreylie ; Powles, Thomas ; Pal, Sumanta Kumar ; Ebrahimi, Hedyeh ; Agarwal, Neeraj ; Beuselinck, Benoit ; Bjarnason, Georg A ; Wood, Lori ; Canil, Christina M ; Saliby, Renee Maria ; de Velasco, Guillermo ; Mckay, Rana R ; Tran, Ben ; Suarez, Cristina ; Templeton, Arnoud J ; Choueiri, Toni K ; Heng, Daniel Yick Chin</creator><creatorcontrib>Ferrier, Evan ; Lemelin, Audreylie ; Powles, Thomas ; Pal, Sumanta Kumar ; Ebrahimi, Hedyeh ; Agarwal, Neeraj ; Beuselinck, Benoit ; Bjarnason, Georg A ; Wood, Lori ; Canil, Christina M ; Saliby, Renee Maria ; de Velasco, Guillermo ; Mckay, Rana R ; Tran, Ben ; Suarez, Cristina ; Templeton, Arnoud J ; Choueiri, Toni K ; Heng, Daniel Yick Chin</creatorcontrib><identifier>ISSN: 0732-183X</identifier><language>eng</language><publisher>LIPPINCOTT WILLIAMS &amp; WILKINS</publisher><ispartof>JOURNAL OF CLINICAL ONCOLOGY, 2024, Vol.42 (4_SUPPL), p.395-395</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,780,27860</link.rule.ids><linktorsrc>$$Uhttps://lirias.kuleuven.be/handle/20.500.12942/751344$$EView_record_in_KU_Leuven_Association$$FView_record_in_$$GKU_Leuven_Association</linktorsrc></links><search><creatorcontrib>Ferrier, Evan</creatorcontrib><creatorcontrib>Lemelin, Audreylie</creatorcontrib><creatorcontrib>Powles, Thomas</creatorcontrib><creatorcontrib>Pal, Sumanta Kumar</creatorcontrib><creatorcontrib>Ebrahimi, Hedyeh</creatorcontrib><creatorcontrib>Agarwal, Neeraj</creatorcontrib><creatorcontrib>Beuselinck, Benoit</creatorcontrib><creatorcontrib>Bjarnason, Georg A</creatorcontrib><creatorcontrib>Wood, Lori</creatorcontrib><creatorcontrib>Canil, Christina M</creatorcontrib><creatorcontrib>Saliby, Renee Maria</creatorcontrib><creatorcontrib>de Velasco, Guillermo</creatorcontrib><creatorcontrib>Mckay, Rana R</creatorcontrib><creatorcontrib>Tran, Ben</creatorcontrib><creatorcontrib>Suarez, Cristina</creatorcontrib><creatorcontrib>Templeton, Arnoud J</creatorcontrib><creatorcontrib>Choueiri, Toni K</creatorcontrib><creatorcontrib>Heng, Daniel Yick Chin</creatorcontrib><title>Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC)</title><title>JOURNAL OF CLINICAL ONCOLOGY</title><issn>0732-183X</issn><fulltext>true</fulltext><rsrctype>other</rsrctype><creationdate>2024</creationdate><recordtype>other</recordtype><sourceid>FZOIL</sourceid><recordid>eNqVjMtKxEAQRbNQcHz8Qy0TYSRJJ8zoTjKKAV8MIu6amqSCrf0I3dWjX-b3mRE_QDf3cuGcu5fM8oUo58VSvBwkhyG85XlRLUU9S77WhBo-nNc9uMidMxTADTAoHxi0sgRpcZuBVVuno8ENoO1BjUor8zPT-_b5AdrHNgNlwRBjYGTVgSc7PXekp0DfKesMQmrWTZNdwKWFOPbIBIN3BviVoLVM3k6q23k7DlbIuMFA0DgbnGcVDaTt3arJjpP9AXWgk98-Sk6vr56am_l71BS3ZGUfRuxIlrms81wW5XlVykVdiKoS_4TP_gxL_mTxDfMxcVA</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Ferrier, Evan</creator><creator>Lemelin, Audreylie</creator><creator>Powles, Thomas</creator><creator>Pal, Sumanta Kumar</creator><creator>Ebrahimi, Hedyeh</creator><creator>Agarwal, Neeraj</creator><creator>Beuselinck, Benoit</creator><creator>Bjarnason, Georg A</creator><creator>Wood, Lori</creator><creator>Canil, Christina M</creator><creator>Saliby, Renee Maria</creator><creator>de Velasco, Guillermo</creator><creator>Mckay, Rana R</creator><creator>Tran, Ben</creator><creator>Suarez, Cristina</creator><creator>Templeton, Arnoud J</creator><creator>Choueiri, Toni K</creator><creator>Heng, Daniel Yick Chin</creator><general>LIPPINCOTT WILLIAMS &amp; WILKINS</general><scope>FZOIL</scope></search><sort><creationdate>20240201</creationdate><title>Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC)</title><author>Ferrier, Evan ; Lemelin, Audreylie ; Powles, Thomas ; Pal, Sumanta Kumar ; Ebrahimi, Hedyeh ; Agarwal, Neeraj ; Beuselinck, Benoit ; Bjarnason, Georg A ; Wood, Lori ; Canil, Christina M ; Saliby, Renee Maria ; de Velasco, Guillermo ; Mckay, Rana R ; Tran, Ben ; Suarez, Cristina ; Templeton, Arnoud J ; Choueiri, Toni K ; Heng, Daniel Yick Chin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_20_500_12942_7513443</frbrgroupid><rsrctype>other</rsrctype><prefilter>other</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ferrier, Evan</creatorcontrib><creatorcontrib>Lemelin, Audreylie</creatorcontrib><creatorcontrib>Powles, Thomas</creatorcontrib><creatorcontrib>Pal, Sumanta Kumar</creatorcontrib><creatorcontrib>Ebrahimi, Hedyeh</creatorcontrib><creatorcontrib>Agarwal, Neeraj</creatorcontrib><creatorcontrib>Beuselinck, Benoit</creatorcontrib><creatorcontrib>Bjarnason, Georg A</creatorcontrib><creatorcontrib>Wood, Lori</creatorcontrib><creatorcontrib>Canil, Christina M</creatorcontrib><creatorcontrib>Saliby, Renee Maria</creatorcontrib><creatorcontrib>de Velasco, Guillermo</creatorcontrib><creatorcontrib>Mckay, Rana R</creatorcontrib><creatorcontrib>Tran, Ben</creatorcontrib><creatorcontrib>Suarez, Cristina</creatorcontrib><creatorcontrib>Templeton, Arnoud J</creatorcontrib><creatorcontrib>Choueiri, Toni K</creatorcontrib><creatorcontrib>Heng, Daniel Yick Chin</creatorcontrib><collection>Lirias (KU Leuven Association)</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ferrier, Evan</au><au>Lemelin, Audreylie</au><au>Powles, Thomas</au><au>Pal, Sumanta Kumar</au><au>Ebrahimi, Hedyeh</au><au>Agarwal, Neeraj</au><au>Beuselinck, Benoit</au><au>Bjarnason, Georg A</au><au>Wood, Lori</au><au>Canil, Christina M</au><au>Saliby, Renee Maria</au><au>de Velasco, Guillermo</au><au>Mckay, Rana R</au><au>Tran, Ben</au><au>Suarez, Cristina</au><au>Templeton, Arnoud J</au><au>Choueiri, Toni K</au><au>Heng, Daniel Yick Chin</au><format>book</format><genre>document</genre><ristype>GEN</ristype><atitle>Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC)</atitle><title>JOURNAL OF CLINICAL ONCOLOGY</title><date>2024-02-01</date><risdate>2024</risdate><volume>42</volume><issue>4_SUPPL</issue><spage>395</spage><epage>395</epage><pages>395-395</pages><issn>0732-183X</issn><pub>LIPPINCOTT WILLIAMS &amp; WILKINS</pub></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0732-183X
ispartof JOURNAL OF CLINICAL ONCOLOGY, 2024, Vol.42 (4_SUPPL), p.395-395
issn 0732-183X
language eng
recordid cdi_kuleuven_dspace_20_500_12942_751344
source Lirias (KU Leuven Association)
title Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A00%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven_FZOIL&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=document&rft.atitle=Real%20world%20outcomes%20of%20first%20line%20(1L)%20nivolumab%20and%20ipilimumab%20(NIVO%20IPI)%20in%20metastatic%20renal%20cell%20carcinoma%20(mRCC):%20An%20update%20from%20the%20International%20mRCC%20Database%20Consortium%20(IMDC)&rft.au=Ferrier,%20Evan&rft.date=2024-02-01&rft.volume=42&rft.issue=4_SUPPL&rft.spage=395&rft.epage=395&rft.pages=395-395&rft.issn=0732-183X&rft_id=info:doi/&rft_dat=%3Ckuleuven_FZOIL%3E20_500_12942_751344%3C/kuleuven_FZOIL%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true